{"id":"W2766145635","doi":"10.1136/annrheumdis-2017-211682","title":"Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"ca_institutions":"St Joseph's Health Care; Western University; Jewish General Hospital","funders":"Roche; U.S. Department of Veterans Affairs","keywords":"Tocilizumab; Medicine; Placebo; Adverse effect; Clinical endpoint; Internal medicine; Surgery; Clinical trial; Gastroenterology; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003680836,0.001070965,0.001694177,0.0004083437,0.0003357836,0.0007570725,0.0005838146,0.001359205,0.004094211],"category_scores_gemma":[0.002887447,0.0004017329,0.001326527,0.0004534104,0.0008398971,0.0006564429,0.000268925,0.001919486,0.0005579585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005686131,"about_ca_system_score_gemma":0.001129225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005201433,"about_ca_topic_score_gemma":0.001051606,"domain_scores_codex":[0.998665,0.0009077896,0.0001061983,0.0001126422,0.0001128309,0.00009549012],"domain_scores_gemma":[0.9978556,0.0005773288,0.0007181818,0.0001411005,0.0001767863,0.0005310685],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9560417,0.008592405,0.001657502,0.000595214,0.0009460403,0.00005734408,0.00008315966,0.0003179077,0.00538479,0.00004985857,0.0006062235,0.02566793],"study_design_scores_gemma":[0.8831533,0.1097648,0.005219188,0.00002636149,0.0003069623,0.0000633069,0.00001596942,0.0002693656,0.0006711003,0.00004726898,0.0004521821,0.00001027395],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991568,0.003640101,0.0005344501,0.0003341888,0.0001430435,0.00218253,0.0007063883,0.00008765238,0.0008036335],"genre_scores_gemma":[0.9869636,0.00270629,0.002003634,0.0007124716,0.0004399336,0.004352327,0.001308353,0.00002221162,0.001491286],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004094211,"threshold_uncertainty_score":0.0194664,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07693841705835605,"score_gpt":0.3406726985918478,"score_spread":0.2637342815334918,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}